Paper · 42927554

Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study.

Canchi Sistla H and 6 others. Mol Biol Rep, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study. Papers, record 42927554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42927554

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study.
Journal: Mol Biol Rep
Year: 2026
Publication types: Journal Article
PubMed: https://pubmed.ncbi.nlm.nih.gov/42927554/
DOI: https://doi.org/10.1007/s11033-026-13003-2
The journal: https://conductscience.org/library/journal-index/0403234
Revised in PubMed: 2026-11-05

Source PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Canchi Sistla H	Harshavardhani
2	Seshachalam A	Arun
3	Rathnam KK	Krishna Kumar
4	Rajagopal T	Taruna
5	Talluri S	Srikanth
6	Venkatabalasubramanian S	Sivaramakrishnan
7	Dunna NR	Nageswara Rao	https://orcid.org/0000-0001-5870-1035

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Matrix Metalloproteinase 1	Major topic
Receptor, Fibroblast Growth Factor, Type 2	Major topic
Ovarian Neoplasms	Major topic
Vascular Endothelial Growth Factor A	Major topic
Humans
Female
Case-Control Studies
Genetic Predisposition to Disease
India
Polymorphism, Single Nucleotide
Middle Aged
Genotype
Adult
South Asian People
Aged
Gene Frequency
Pilot Projects

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
SASTRA-TRR-SCBT-1-11092024	SASTRA University			PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	32,606,233	Ovarian Cancer: An Overview.	Radiol Technol	2020	https://conductscience.org/library/papers/32606233	PubMed
2	18,705,799	The effect of a single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter on force-induced MMP-1 expression in human periodontal ligament cells.	Eur J Oral Sci	2008	https://conductscience.org/library/papers/18705799	PubMed
3	15,274,394	Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.	Anticancer Res	2004	https://conductscience.org/library/papers/15274394	PubMed
4	32,765,800	Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.	Hered Cancer Clin Pract	2020	https://conductscience.org/library/papers/32765800	PubMed
5	15,474,975	MMP-1: the elder of the family.	Int J Biochem Cell Biol	2005	https://conductscience.org/library/papers/15474975	PubMed
6	33,273,524	MassArray analysis of genomic susceptibility variants in ovarian cancer.	Sci Rep	2020	https://conductscience.org/library/papers/33273524	PubMed
7	26,264,619	Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.	Tumour Biol	2016	https://conductscience.org/library/papers/26264619	PubMed
8	33,170,424	Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer.	Mol Biol Rep	2020	https://conductscience.org/library/papers/33170424	PubMed
9	25,253,367	Role of interstitial collagenase gene promoter polymorphism in the etiology of gastric cancer.	Saudi J Gastroenterol	2014	https://conductscience.org/library/papers/25253367	PubMed
10	40,564,842	Matrix Metalloproteinases 1 and 3 in Ovarian Cancer: Diagnostic and Prognostic Potential of Genetic Variants and Expression Profiling.	Diagnostics (Basel)	2025	https://conductscience.org/library/papers/40564842	PubMed

1 to 10 of 36

See all 36 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42927554

GET https://conductscience.org/api/papers/v1/42927554/references?page=2

API reference For AI assistants